re: Ann: ADI: Supplementary Target's Stat... There is a reason why AWE is cheap at the moment....no one wants it!Cheers,
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025